Centro de Estudios Científicos - Academic Profile

Publications

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer , Karen L. Reckamp , Paul Baas +22 more

Among patients with advanced, previously treated squamous-cell NSCLC, overall survival, response rate, and progression-free survival were significantly better with nivolumab tha...

2015 New England Journal of Medicine 8355 citations

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer , Nizar M. Tannir , Ray McDermott +29 more

Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previo...

2018 New England Journal of Medicine 4403 citations

Affiliated Researchers

Osvaldo Arén Frontera

Centro de Estudios Científicos

Institution Info

Type: nonprofit
Country: CL
Publications: 2
Citations: 12,758

External Links

Identifiers

ROR: https://ror.org/00t8xfq63